This list reflects information regarding the applications as of the approval date. It is not updated with regard to applicant or application status changes.
|Tradename||Indication for Use||NDA Number||Applicant||Approval Date|
|Anticoagulant Citrate Dextrose Solution, USP (ACD-A)||For the extracorporeal processing of blood with Autologous PRP systems in production of platelet rich plasma (PRP) for in vitro use.||BA110057||Arteriocyte Medical Systems, Inc.|
45 South Street, Suite 3
Hopkinton, MA 01748